Psoriasis
News
New Psoriasis Biologics Achieve Promising Phase II Results
Major Finding: Two new biologic agents directed against IL-17 achieved 12-week PASI 75 response rates of about 80%.Data Source: Four double-blind...
News
Briakinumab Tops Methotrexate for Psoriasis in Phase III Study
Major Finding: More patients receiving briakinumab showed at least a 75% improvement in PASI scores at week 24 (81.8%) and week 52 (66.2%),...
News
Registry Updates Blau Diagnostic Criteria
News
Psoriatic Arthritis: Evidence Lacking for Widespread Methotrexate Use
News
Scleroderma: Research Locally, Share Globally
News
New Psoriatic Arthritis Guidelines Highlight Paucity of Data
Major Finding: New recommendations on the treatment of PsA emphasize early use of disease-modifying antirheumatic drugs, as well as anti–tumor...
News
Metal Orthopedic Implants Unlikely to Trigger Allergy
News
Pharma-Sponsored Comparison Studies Hold Clinical Value
Article
An Open-label, Multicenter Study of the Efficacy and Safety of a Weekday/Weekend Treatment Regimen With Calcitriol Ointment 3 μg/g and Clobetasol Propionate Spray 0.05% in the Management of Plaque Psoriasis
High-potency topical corticosteroids are the cornerstone of psoriasis therapy. Although highly effective, long-term use of topical steroids can...
News
Researchers Confirm Psoriatic Arthritis Risk Allele
Major Finding: TNF*-857T is a susceptibility allele for PsA independent of the main PSORS1 risk allele.Data Source: A study of 2,224 individuals...